Dual drug Piperine-Paclitaxel nanoparticles inhibit migration and invasion in human breast cancer cells.
Dr Monika Verma
Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C
Dr Louise Young
Clinical response to tepotinib according to circulating tumor (ct)DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)
Dr Louise Young
USING EX VIVO BIOENGINEERED LUNGS TO MODEL PATHOLOGIES AND SCREENING THERAPEUTICS
Mr Mohammadali Ahmadipour
Surgical Outcomes of Lung Cancer Surgery in Tasmania
Dr Ayeshmanthe Rathnayake
Real-world outcomes for patients with pleural mesothelioma: a multisite retrospective cohort study.
Dr Kar Ven Cavan Chow
RETROSPECTIVE COHORT STUDY MAPPING THE CLINICAL CARE PATHWAYS FOR ADVANCED STAGE VICTORIAN NON-SMALL CELL LUNG CANCER PATIENTS: DETECTING OPPORTUNITIES FOR IMPROVED SUPPORTIVE AND PALLIATIVE CARE
Ms Shantelle Smith
Multiomic dissection of immunotherapy response groups in lung cancer
Dr Arutha Kulasinghe
Concurrent right-sided bronchial-pulmonary artery fistula and left-sided basaloid squamous cell carcinoma in a patient with recurrent haemoptysis
Dr Natalie Nguyen
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry (ANZLCR): A protocol paper.
A/Prof Rob Stirling
Activin-A, GDF-11 and TGF-beta as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer
Dr Jennifer Lim
Extracellular Matrix Profiles Determine Risk and Prognosis of the Squamous Cell Carcinoma Subtype of Non-Small Cell Lung Carcinoma
Dr Amelia Parker
Patterns of care for Small Cell Lung Cancer in Victoria, Australia : An observational cohort study
A/Prof Rob Stirling
Receipt of Guideline-Concordant Treatment in Lung Cancer by hospital insurance status in Victoria, Australia: A population based, propensity matched observational study.
Rob Stirling
Prevalence of incidental lung cancer detected at autopsy: a systematic review.
Dr Asha Bonney
A retrospective analysis of patterns of care and clinical outcomes for people diagnosed with mesothelioma in Victoria
Susan Harden
Utilisation of thoracic radiotherapy for extensive stage small cell lung cancer in the era of chemoimmunotherapy: Experience from a multisite retrospective cohort study
Dr Cassie Turner
Increased epithelial-mesenchymal transition (EMT) changes in smokers and COPD with non-small cell lung cancer
Dr Wenying Lu
A snapshot of lung cancer in a regional Queensland hospital
Dr Jocelyne Desoe
The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance
Dr Sharron Liang
Comparison of the 7th and 8th editions of AJCC TNM staging for non-small cell lung cancer: a population-based study in Queensland, Australia
Ms Shoni Philpot
Role of hybrid FDG PET/contrast CT parameters at early restaging for subsequent response to immunotherapy in advanced NSCLC
Dr Dalveer Singh
Empowering peer-to-peer connection: Transitioning Peer Support from a nurse-led phone program to a peer-led multimodal online group – increasing engagement
Miss Sahba Dehghani
Incidence and mortality from mesothelioma 1982-2020: the Australian Mesothelioma Registry
Prof Fraser Brims
12-month experience of a private university hospital multi-disciplinary team (MDT)
Mrs Abby Fyfe
Non-small cell lung cancer in Victoria: Association between stage-specific receipt of guideline-concordant treatment and survival
Ms Sanuki Tissera
Small cell lung cancer in Victoria: The association between stage-specific guideline concordant treatment and survival
Ms Sanuki Tissera
Defining tetranucleotide repeat instability as a marker of deficient DNA repair in lung cancer.
Miss Hannah Parker
Feasibility and effects of a lung cancer prehabilitation exercise program
Ms Kirsten Mooney
Exploring the lung microbiome using metagenomics in an Australian cohort of people with lung cancer
A/Prof Bryan Chan
Delays to lung cancer surgery and pathological upstaging in a Western Australian tertiary centre
Dr Nicholas Bayfield
Comparison of twelve lung cancer prediction scores on baseline CT scan in a lung cancer screening cohort
Dr Paul Dawkins
Sleep Quality Before and After Chemotherapy in Lung Cancer Patients - A Systematic Review and Meta-Analysis
Dr RIshi Kumarahuru
First 110 cases of robotic-assisted thoracic surgery in Geelong, Australia. A cohort study.
Dr Manoras Mathew Chengalath
Stage III Non Small Cell Lung Cancer curative intent treatment: Does post code matter?
Ms Catherine Smith
Lung cancer screening in asbestos-exposed individuals: implications for risk-based eligibility
Dr Jessica Nash
The Long Haul: Ongoing COVID-19 symptoms and the needs of Australians
Miss Letisha Hatte
Smoking cessation, quit attempts and smoking cessation interventions in a cohort undergoing lung cancer screening in the International Lung Screen Trial
Dr Samantha Kung
Addressing “Near-Miss” Cases: Considerations for Risk-Based Recruitment in Lung Cancer Screening Programs
Mr Chellan Kumarasamy
Coping and adjustment to lung cancer in the immunotherapy and targeted therapies era: Experiences of Australian Lung Cancer Survivors
Dr Rebekah Laidsaar-Powell
The development of a new chapter of Cancer Council's National Cancer Prevention Policy on lung cancer screening in Australia.
Ms Joanna McGlone, Ms Amanda McAtamney, Prof Tanya Buchanan
Lung cancer risk in Quitline Clients
A/Prof Henry Marshall
20 years of progress; The Prince Charles Hospital Lung Bank and its role in advancing lung cancer laboratory, clinical and molecular research
Dr Kelly Tian Mun Chee
Biomarkers of lung cancer in never-smokers: current evidence
Mr Edward Stephens
Biomarkers for lung cancer screening - systematic review
Ms. Jazmin Guayco
Applicability of lung cancer resection specimens donated to a prospective Lung Bank for genomic research focus on lung cancer in never smokers (LCINS)
Dr Kelly Tian Mun Chee
Small RNA Sequencing from EV-Enriched and Unenriched Plasma Fractions to Differentiate Between NSCLC With and Without Nodal Metastasis
Ms Elizabeth Keir
COVID-19 impacts on lung cancer diagnosis, management and timeliness in Victoria, Australia: A population based observational study
A/Prof Rob Stirling
The Lung Cancer Nurse Specialist: Co-designing the role with Patients and Carers
Ms Renae Grundy
Lung cancer – a silent spectre in former dust exposed workers
Catherine Jones
Judges Comments